Novel Hyangnam Bioplant Valued at $117.9M as Daewoong Bio Enters CDMO Business
With 146 billion won, Daewoong Bio intends to enter the contract development and manufacturing organization (CDMO) market.
With 146 billion won, Daewoong Bio intends to enter the contract development and manufacturing organization (CDMO) market.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings